Lineage Cell Therapeutics
LCTX
#8223
Rank
A$0.23 B
Marketcap
$1.27
Share price
1.22%
Change (1 day)
-36.48%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Net assets

Net assets on the balance sheet as of June 2024 : A$99.03 M

According to Lineage Cell Therapeutics 's latest financial reports the company has A$99.03 M in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lineage Cell Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$91.03 M-13.88%
2022-12-31$A$0.10 B-15.69%
2021-12-31$A$0.12 B1.35%
2020-12-31$A$0.12 B-22.14%
2019-12-31$A$0.15 B21.34%
2018-12-31$A$0.13 B-37.77%
2017-12-31$A$0.21 B16.21%
2016-12-31$A$0.18 B72.53%
2015-12-31$A$0.10 B36.92%
2014-12-31$A$76.64 M61.76%
2013-12-31$A$47.38 M102.67%
2012-12-31$A$23.37 M-42.18%
2011-12-31$A$40.43 M-16.9%
2010-12-31$A$48.65 M295.67%
2009-12-31$A$12.29 M-299.6%
2008-12-31$-A$6.17 M76.82%
2007-12-31$-A$3.49 M47.26%
2006-12-31$-A$2.37 M780.71%
2005-12-31$-A$0.27 M-160.3%
2004-12-31$A$0.44 M-113.62%
2003-12-31$-A$3.27 M57.31%
2002-12-31$-A$2.08 M970.57%
2001-12-31$-A$0.2 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$0.44 B 352.19%๐Ÿ‡บ๐Ÿ‡ธ USA